Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
Although these drugs demonstrated effectiveness in improving blood sugar control and promoting weight loss, lawsuits now allege that GLP-1 receptor agonists may also be associated with severe gastrointestinal injuries, optic nerve complications, and other serious adverse health effects
For GLP-1 users specifically, the challenge is that reduced food intake also means reduced dietary fiber intake
Clinicians will review your online questionnaire and will recommend the most appropriate weight loss treatments for you based on your answers
Canadian Employer Plans Covering GLP-1s for Weight Loss Have Nearly Doubled Data from the International Foundation of Employee Benefit Plans (IFEBP) 2025 Pulse Survey shows a significant shift in Canadian employer attitudes toward GLP-1 coverage: 31% of employer plans now cover GLP-1s for weight loss (up from 17% in 2024) 56% cover for diabetes only (down from 66% in 2024) 20% of diabetes-only plans are considering adding obesity coverage Provincial public drug plans still cover semaglutide only for type 2 diabetes not for weight loss
US$ 27.01
US$ 24.86
US$ 28.49
US$ 26.43
US$ 21.26
US$ 29.11
US$ 27.57
